Surface proteins of Staphylococcus aureus play an important role in experimental skin infection

APMIS

Volumn 122, Issue 12, 2014, Pages 1240-1250

  Kwiecinski, Jakub ^a   Jin, Tao ^a   Josefsson, Elisabet ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

SSTI; Abscess; Necrosis; Skin; Staphylococcus aureus; Surface proteins; Virulence

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN; MYELOPEROXIDASE; PROTEIN A; SORTASE; SURFACE PROTEIN SASF; UNCLASSIFIED DRUG; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; COAGULASE; STAPHYLOCOCCUS PROTEIN A; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL WALL; BACTERIAL CLEARANCE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATORY INFILTRATE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ABSCESS; SKIN NECROSIS; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ANIMAL; CELL WALL; DISEASE MODEL; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; SKIN DISEASE; STAPHYLOCOCCUS INFECTION;

ANIMALS; CELL WALL; COAGULASE; DISEASE MODELS, ANIMAL; FEMALE; MEMBRANE PROTEINS; MICE; SKIN DISEASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

EID: 84922481554     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/apm.12295     Document Type: Article

References (41)

1. Dryden MS. Skin and soft tissue infection: microbiology and epidemiology. Int J Antimicrob Agents 2009;34(Suppl 1):S2-7.
2. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol 2011;11:505-18.
3. Hedström SÅ. Skin and soft tissue infections. In: Espersen F, Hedström SÅ, Solberg CO, editors. The Ever Present Pathogens. An Update on Staphylococci and Staphylococcal Infections. Göteborg: Pharmacia & Upjohn, 1999: 185-207.
4. Sreeramoju P, Porbandarwalla NS, Arango J, Latham K, Dent DL, Stewart RM, et al. Recurrent skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus requiring operative debridement. Am J Surg 2011;201:216-20.
5. Jacobsson G, Gustafsson E, Andersson R. Outcome for invasive Staphylococcus aureus infections. Eur J Clin Microbiol Infect Dis 2008;27:839-48.
6. Cheung GY, Wang R, Khan BA, Sturdevant DE, Otto M. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect Immun 2011;79:1927-35.
7. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011;204:937-41.
8. Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS. CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300. Infect Immun 2012;80:2382-9.
9. del Giudice P, Blanc V, de Rougemont A, Bes M, Lina G, Hubiche T, et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 2009;219:299-302.
10. Iwatsuki K, Yamasaki O, Morizane S, Oono T. Staphylococcal cutaneous infections: invasion, evasion and aggression. J Dermatol Sci 2006;42:203-14.
11. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, Braughton KR, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 2010;202:1050-8.
12. Lipinska U, Hermans K, Meulemans L, Dumitrescu O, Badiou C, Duchateau L, et al. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 2011;6:e22864.
13. Sjolund M, Kahlmeter G. Staphylococci in primary skin and soft tissue infections in a Swedish county. Scand J Infect Dis 2008;40:894-8.
14. Koziel J, Potempa J. Protease-armed bacteria in the skin. Cell Tissue Res 2013;351:325-37.
15. Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 2005;202:209-15.
16. Clarke SR, Foster SJ. Surface adhesins of Staphylococcus aureus. Adv Microb Physiol 2006;51:187-224.
17. Foster TJ, Geoghegan JA, Ganesh VK, Höök M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol 2014;12:49-62.
18. Jonsson IM, Mazmanian SK, Schneewind O, Bremell T, Tarkowski A. The role of Staphylococcus aureus sortase A and sortase B in murine arthritis. Microbes Infect 2003;5:775-80.
19. McDevitt D, Francois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol 1995;16:895-907.
20. McDevitt D, Francois P, Vaudaux P, Foster TJ. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol Microbiol 1994;11:237-48.
21. Josefsson E, Higgins J, Foster TJ, Tarkowski A. Fibrinogen binding sites P336 and Y338 of clumping factor A are crucial for Staphylococcus aureus virulence. PLoS ONE 2008;3:e2206.
22. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, Rees HH, et al. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS ONE 2009;4:e4344.
23. Palmqvist N, Foster T, Fitzgerald JR, Josefsson E, Tarkowski A. Fibronectin-binding proteins and fibrinogen-binding clumping factors play distinct roles in staphylococcal arthritis and systemic inflammation. J Infect Dis 2005;191:791-8.
24. Kwiecinski J, Josefsson E, Mitchell J, Higgins J, Magnusson M, Foster T, et al. Activation of plasminogen by staphylokinase reduces the severity of Staphylococcus aureus systemic infection. J Infect Dis 2010;202:1041-9.
25. Mölne L, Tarkowski A. An experimental model of cutaneous infection induced by superantigen-producing Staphylococcus aureus. J Invest Dermatol 2000;114:1120-5.
26. Kwiecinski J, Josefsson E, Jin T. Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease. Inflamm Res 2011;60:1021-9.
27. Liese J, Rooijakkers SH, van Strijp JA, Novick RP, Dustin ML. Intravital two-photon microscopy of host-pathogen interactions in a mouse model of Staphylococcus aureus skin abscess formation. Cell Microbiol 2013;15:891-909.
28. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, Missiakas DM. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J 2009;23:3393-404.
29. Mazmanian SK, Liu G, Jensen ER, Lenoy E, Schneewind O. Staphylococcus aureus sortase mutants defective in the display of surface proteins and in the pathogenesis of animal infections. Proc Natl Acad Sci U S A 2000;97:5510-5.
30. Palmqvist N, Foster T, Tarkowski A, Josefsson E. A protein is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog 2002;33:239-49.
31. Patel AH, Nowlan P, Weavers ED, Foster T. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 1987;55:3103-10.
32. White MI, Noble WC. The cutaneous reaction to staphylococcal protein A in normal subjects and patients with atopic dermatitis or psoriasis. Br J Dermatol 1985;113:179-83.
33. Dziewanowska K, Patti JM, Deobald CF, Bayles KW, Trumble WR, Bohach GA. Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun 1999;67:4673-8.
34. Edwards AM, Potts JR, Josefsson E, Massey RC. Staphylococcus aureus host cell invasion and virulence in sepsis is facilitated by the multiple repeats within FnBPA. PLoS Pathog 2010;6:e1000964.
35. Mempel M, Schmidt T, Weidinger S, Schnopp C, Foster T, Ring J, et al. Role of Staphylococcus aureus surface-associated proteins in the attachment to cultured HaCaT keratinocytes in a new adhesion assay. J Invest Dermatol 1998;111:452-6.
36. Shinji H, Yosizawa Y, Tajima A, Iwase T, Sugimoto S, Seki K, et al. Role of fibronectin-binding proteins A and B in in vitro cellular infections and in vivo septic infections by Staphylococcus aureus. Infect Immun 2011;79:2215-23.
37. McElroy MC, Cain DJ, Tyrrell C, Foster TJ, Haslett C. Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia. Infect Immun 2002;70:3865-73.
38. Shryock TR, Kapral FA. The production of bactericidal fatty acids from glycerides in staphylococcal abscesses. J Med Microbiol 1992;36:288-92.
39. Josefsson E, Hartford O, O'Brien L, Patti JM, Foster T. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001;184:1572-80.
40. Moreillon P, Entenza JM, Francioli P, McDevitt D, Foster TJ, Francois P, et al. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect Immun 1995;63:4738-43.
41. Hair PS, Echague CG, Sholl AM, Watkins JA, Geoghegan JA, Foster TJ, et al. Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis. Infect Immun 2010;78:1717-27.